PortalPublikationenComplementary therapy use in patients with glioma: an observ...

Complementary therapy use in patients with glioma: an observational study.

Standard

Complementary therapy use in patients with glioma: an observational study. / Heese, Oliver; Schmidt, M; Nickel, Stefan; Berger, H; Goldbrunner, R; Tonn, J C; Bhär, O; Steinbach, J P; Simon, M; Schramm, J; Krex, D; Schackert, G; Reithmeier, T; Nikkhah, G; Löffler, M; Weller, M; Westphal, Manfred.

in: NEUROLOGY, Jahrgang 75, Nr. 24, 24, 2010, S. 2229-2235.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Heese, O, Schmidt, M, Nickel, S, Berger, H, Goldbrunner, R, Tonn, JC, Bhär, O, Steinbach, JP, Simon, M, Schramm, J, Krex, D, Schackert, G, Reithmeier, T, Nikkhah, G, Löffler, M, Weller, M & Westphal, M 2010, 'Complementary therapy use in patients with glioma: an observational study.', NEUROLOGY, Jg. 75, Nr. 24, 24, S. 2229-2235. <http://www.ncbi.nlm.nih.gov/pubmed/21172846?dopt=Citation>

APA

Heese, O., Schmidt, M., Nickel, S., Berger, H., Goldbrunner, R., Tonn, J. C., Bhär, O., Steinbach, J. P., Simon, M., Schramm, J., Krex, D., Schackert, G., Reithmeier, T., Nikkhah, G., Löffler, M., Weller, M., & Westphal, M. (2010). Complementary therapy use in patients with glioma: an observational study. NEUROLOGY, 75(24), 2229-2235. [24]. http://www.ncbi.nlm.nih.gov/pubmed/21172846?dopt=Citation

Vancouver

Heese O, Schmidt M, Nickel S, Berger H, Goldbrunner R, Tonn JC et al. Complementary therapy use in patients with glioma: an observational study. NEUROLOGY. 2010;75(24):2229-2235. 24.

Bibtex

@article{dfd4798800ce4e86a1b7667f44c6474e,
title = "Complementary therapy use in patients with glioma: an observational study.",
abstract = "Despite novel multimodal therapeutic approaches, the vast majority of glial tumors are not curable. Patients may search for complementary therapies in order to contribute to the fight against their disease or to relieve symptoms induced by their brain tumor. The extent of the use of complementary or alternative therapies, the patients' rationale behind it, and the cost of complementary therapy for gliomas are not known. We used a questionnaire and the database of the German Glioma Network to evaluate these questions.",
keywords = "Humans, Male, Aged, Female, Middle Aged, Questionnaires, Severity of Illness Index, Sex Factors, Treatment Outcome, Age Factors, Germany epidemiology, Brain pathology, Brain Neoplasms pathology, Complementary Therapies methods, Glioma pathology, Observation, Humans, Male, Aged, Female, Middle Aged, Questionnaires, Severity of Illness Index, Sex Factors, Treatment Outcome, Age Factors, Germany epidemiology, Brain pathology, Brain Neoplasms pathology, Complementary Therapies methods, Glioma pathology, Observation",
author = "Oliver Heese and M Schmidt and Stefan Nickel and H Berger and R Goldbrunner and Tonn, {J C} and O Bh{\"a}r and Steinbach, {J P} and M Simon and J Schramm and D Krex and G Schackert and T Reithmeier and G Nikkhah and M L{\"o}ffler and M Weller and Manfred Westphal",
year = "2010",
language = "Deutsch",
volume = "75",
pages = "2229--2235",
journal = "NEUROLOGY",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "24",

}

RIS

TY - JOUR

T1 - Complementary therapy use in patients with glioma: an observational study.

AU - Heese, Oliver

AU - Schmidt, M

AU - Nickel, Stefan

AU - Berger, H

AU - Goldbrunner, R

AU - Tonn, J C

AU - Bhär, O

AU - Steinbach, J P

AU - Simon, M

AU - Schramm, J

AU - Krex, D

AU - Schackert, G

AU - Reithmeier, T

AU - Nikkhah, G

AU - Löffler, M

AU - Weller, M

AU - Westphal, Manfred

PY - 2010

Y1 - 2010

N2 - Despite novel multimodal therapeutic approaches, the vast majority of glial tumors are not curable. Patients may search for complementary therapies in order to contribute to the fight against their disease or to relieve symptoms induced by their brain tumor. The extent of the use of complementary or alternative therapies, the patients' rationale behind it, and the cost of complementary therapy for gliomas are not known. We used a questionnaire and the database of the German Glioma Network to evaluate these questions.

AB - Despite novel multimodal therapeutic approaches, the vast majority of glial tumors are not curable. Patients may search for complementary therapies in order to contribute to the fight against their disease or to relieve symptoms induced by their brain tumor. The extent of the use of complementary or alternative therapies, the patients' rationale behind it, and the cost of complementary therapy for gliomas are not known. We used a questionnaire and the database of the German Glioma Network to evaluate these questions.

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Questionnaires

KW - Severity of Illness Index

KW - Sex Factors

KW - Treatment Outcome

KW - Age Factors

KW - Germany epidemiology

KW - Brain pathology

KW - Brain Neoplasms pathology

KW - Complementary Therapies methods

KW - Glioma pathology

KW - Observation

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Questionnaires

KW - Severity of Illness Index

KW - Sex Factors

KW - Treatment Outcome

KW - Age Factors

KW - Germany epidemiology

KW - Brain pathology

KW - Brain Neoplasms pathology

KW - Complementary Therapies methods

KW - Glioma pathology

KW - Observation

M3 - SCORING: Zeitschriftenaufsatz

VL - 75

SP - 2229

EP - 2235

JO - NEUROLOGY

JF - NEUROLOGY

SN - 0028-3878

IS - 24

M1 - 24

ER -